Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.
Press releases published on May 8, 2025

Wild Interest Podcast Takes Us Back to US Shock Olympic Win, Talks Pro Parenting with Influencer Jayme Yannuzzi
“Miracle On Ice” Surprise 1980 US Olympic Victory, Youth Hockey in Lake Placid, NY Today, and Motherhood Influencer Jayme Yannuzzi of “Teach Talk Inspire.” NEW YORK, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- "Wild Interest" is the podcast …

OPEN Announces First Close of the OPEN Unicorn® Index Fund
NEW YORK, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- OPEN, a pioneer in private market indexing, today announced the successful first close of its flagship OPEN Unicorn® Index Fund (“the Fund”). The Fund provides diversified, rules-based access …

Bluecore Expands Beyond Enterprise; Launches AI Shopping Agent alby to All Retailers on Shopify
With alby by Bluecore, Thousands of Shopify Merchants Can Now Launch Conversational AI Shopping Experiences Across Their Ecommerce Sites in One Hour NEW YORK, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Bluecore, the technology company that …

90 Days to AI-Ready: Sherweb Enables Fleet of MSPs to Jump Start AI Adoption for 100K+ Companies
The MSP Technology and Service Provider is Scaling MSPs’ Ability to Deliver on Market Demand for AI Capabilities–and the Data Foundation to Support Them NEW YORK, NY, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- Sherweb, the technology and service …

LocaChange Releases Comprehensive Life360 Data Analysis: Insights into User Growth, Revenue Trends, and Privacy Concerns
LocaChange reveals key Life360 user, revenue, and privacy trends in its 2025 data analysis, helping families understand app benefits and risks. NEW YORK CITY, NY, CHINA, May 8, 2025 /EINPresswire.com/ -- In response to the rising concerns over digital …

Koss Corporation Reports Third Quarter Results
MILWAUKEE, May 08, 2025 (GLOBE NEWSWIRE) -- Koss Corporation (NASDAQ: KOSS) (the “Company”), the U.S. based high-fidelity headphone company, has reported its results for the third quarter ended March 31, 2025. Net sales for the three months ended March 31, …

Draganfly Announces First Quarter Results of 2025
Vancouver, BC., May 08, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter …

Logan Ridge Finance Corporation Announces First Quarter 2025 Financial Results
Reports Solid First Quarter Results with Net Investment Income of $0.35 Per Share and a Net Asset Value of $29.66 Per Share Declared a Distribution of $0.36 Per Share for the Second Quarter of 2025 Successfully Exited its Equity Investment in GA …

Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update
-- Company delivers on mission to transform women’s health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 08, …

Navient declares second quarter common stock dividend
HERNDON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced that its board of directors approved a 2025 second quarter dividend of $0.16 per share on the company's common stock. The second quarter 2025 dividend will be paid on June 20, …

Tarsus to Participate in Upcoming Investor Conferences
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Portman Ridge Finance Corporation Announces First Quarter 2025 Financial Results
Reports Net Investment Income of $0.47 Per Share and Net Asset Value of $18.85 Per Share Deployment of Approximately $17.5 Million and Sales and Repayments of Approximately $15.7 Million for Net Deployment of Approximately $1.8 Million Announces Second …

Alliance Entertainment to Host Third Quarter Fiscal Year 2025 Results Conference Call on May 15 at 4:30 p.m. Eastern Time
PLANTATION, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and fulfillment partner of entertainment and pop culture collectibles, will hold a conference call on Thursday, May 15, at 4 …

Innospec Reports First Quarter 2025 Financial Results
Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend …

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
- Sharpened product candidate focus on its next-generation ADC portfolio, following strategic review and pipeline reprioritization - - Promising preclinical results with STRO-004 and dual-payload ADC, as well as STRO-006 programs presented at AACR 2025 and …

Hepsiburada Announces First Quarter 2025 Financial Results
ISTANBUL, May 08, 2025 (GLOBE NEWSWIRE) -- D-MARKET Electronic Services …

Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets
Pre-NDA Meeting for CTx-1301(dexmethylphenidate) Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of CTx-2103 (buspirone) KANSAS CITY, Kan., May 08, 2025 (GLOBE NEWSWIRE) -- Cingulate …

BioSyent Schedules First Quarter Earnings Release for May 15, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …

Galecto Reports First Quarter 2025 Operating and Financial Results
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …